Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF-680 After Multiple Oral Doses” in Healthy Volunteers.

Condition:   Asthma
Interventions:   Drug: PBF-680;   Drug: Placebo
Sponsors:   Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau;   Palo Biofarma, S.L
Recruiting – verified August 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days